BRCA2 and osteosarcoma: Both yielded significantly increased median sensitivity for the RB1-defective compared to the RB1-normal osteosarcoma group, with sensitivities across the RB1-defective group greater than, or closely matching that of BRCA2-mutated CAPAN1 (Fig. 1b, d, f).